GEMOAB MONOCLONALS GMBH

Their modular antibody-complex technology combines the target-binding moieties of different antibodies. Together with the multi-functional linker of their modular system, they constitute the innovative GEMoaB constructs (Figure). These bi- or multi-specific antibody complexes have comparable functionality and efficacy to conventional bi- or multi-specific antibodies; however their development time is significantly shortened.